Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Arsenic patent keeps drug for rare cancer out of reach of many

Nature Medicine volume 13, page 1005 (2007)Cite this article

A Correspondence to this article was published on 01 November 2007

Patent should never have been granted, critics charge.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Tokyo

    David Cyranoski

Authors
  1. David Cyranoski
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related external links

Arsenic Trioxide

Acute Promyelocytic Leukemia

Trisenox

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyranoski, D. Arsenic patent keeps drug for rare cancer out of reach of many. Nat Med 13, 1005 (2007). https://doi.org/10.1038/nm0907-1005

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0907-1005

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing